By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Alvotech

Alvotech (ALVOW)

NASDAQ Currency in USD
$1.11
-$0.06
-4.93%
Last Update: 11 Sept 2025, 19:54
$2.31B
Market Cap
1.85
P/E Ratio (TTM)
Forward Dividend Yield
$0.97 - $1.17
52 Week Range

ALVOW Stock Price Chart

Explore Alvotech interactive price chart. Choose custom timeframes to analyze ALVOW price movements and trends.

ALVOW Company Profile

Discover essential business fundamentals and corporate details for Alvotech (ALVOW) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

16 Jun 2022

Employees

1.01K

CEO

Robert Wessman

Description

Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.

ALVOW Financial Timeline

Browse a chronological timeline of Alvotech corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 13 Aug 2025

EPS came in at $0.03 surpassing the estimated -$0.05 by +166.06%, while revenue for the quarter reached $173.34M , beating expectations by +47.73%.

ALVOW Stock Performance

Access detailed ALVOW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run